JP Morgan Chase’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.1M Sell
260,200
-86,800
-25% -$20.2M ﹤0.01% 1242
2025
Q4
$71.8M Buy
347,000
+210,800
+155% +$41.7M ﹤0.01% 1129
2025
Q3
$25.3M Sell
136,200
-145,400
-52% -$24.9M ﹤0.01% 1911
2025
Q2
$43M Buy
281,600
+196,600
+231% +$30.2M ﹤0.01% 1421
2025
Q1
$14.1M Sell
85,000
-58,000
-41% -$9.08M ﹤0.01% 2229
2024
Q4
$20.7M Buy
143,000
+38,800
+37% +$6.01M ﹤0.01% 2016
2024
Q3
$16.9M Buy
104,200
+94,300
+953% +$15M ﹤0.01% 2139
2024
Q2
$1.45M Sell
9,900
-60,100
-86% -$8.94M ﹤0.01% 4013
2024
Q1
$11.1M Sell
70,000
-172,200
-71% -$27.4M ﹤0.01% 2383
2023
Q4
$38M Buy
242,200
+126,800
+110% +$19.4M ﹤0.01% 1380
2023
Q3
$18M Buy
115,400
+34,600
+43% +$5.71M ﹤0.01% 1764
2023
Q2
$13.4M Sell
80,800
-113,700
-58% -$18.4M ﹤0.01% 2029
2023
Q1
$30.1M Sell
194,500
-180,900
-48% -$29.2M ﹤0.01% 1362
2022
Q4
$66.3M Sell
375,400
-53,200
-12% -$9.19M 0.01% 964
2022
Q3
$70M Buy
428,600
+233,300
+119% +$39.5M 0.01% 888
2022
Q2
$34.7M Sell
195,300
-31,900
-14% -$5.68M ﹤0.01% 1243
2022
Q1
$40.3M Buy
227,200
+107,200
+89% +$18.2M ﹤0.01% 1285
2021
Q4
$20.5M Buy
120,000
+2,500
+2% +$409K ﹤0.01% 1811
2021
Q3
$19M Sell
117,500
-13,800
-11% -$2.35M ﹤0.01% 1811
2021
Q2
$21.6M Buy
131,300
+130,600
+18,657% +$21.6M ﹤0.01% 1771
2021
Q1
$115K Sell
700
-19,200
-96% -$3.11M ﹤0.01% 5339
2020
Q4
$3.13M Sell
19,900
-23,100
-54% -$3.41M ﹤0.01% 3168
2020
Q3
$6.32M Buy
43,000
+23,500
+121% +$3.48M ﹤0.01% 2367
2020
Q2
$2.74M Sell
19,500
-13,200
-40% -$1.92M ﹤0.01% 2896
2020
Q1
$4.29M Sell
32,700
-449,400
-93% -$63.8M ﹤0.01% 2396
2019
Q4
$70.3M Buy
482,100
+30,100
+7% +$4.08M 0.01% 799
2019
Q3
$58.5M Sell
452,000
-82,300
-15% -$10.8M 0.01% 874
2019
Q2
$75.2M Buy
534,300
+56,200
+12% +$7.78M 0.01% 782
2019
Q1
$66.8M Buy
478,100
+193,400
+68% +$25.9M 0.01% 825
2018
Q4
$36.7M Buy
284,700
+71,600
+34% +$9.99M 0.01% 1055
2018
Q3
$29.4M Buy
213,100
+12,500
+6% +$1.66M 0.01% 1355
2018
Q2
$24.3M Buy
200,600
+40,700
+25% +$5.08M 0.01% 1435
2018
Q1
$20.5M Sell
159,900
-75,300
-32% -$10.2M ﹤0.01% 1490
2017
Q4
$32.9M Buy
235,200
+184,900
+368% +$25.8M 0.01% 1219
2017
Q3
$6.51M Hold
50,300
﹤0.01% 2356
2017
Q2
$6.65M Sell
50,300
-120,700
-71% -$15.4M ﹤0.01% 2278
2017
Q1
$21.3M Sell
171,000
-5,000
-3% -$597K ﹤0.01% 1434
2016
Q4
$20.3M Sell
176,000
-75,532
-30% -$8.72M ﹤0.01% 1464
2016
Q3
$29.7M Sell
251,532
-40,300
-14% -$4.89M 0.01% 1119
2016
Q2
$35.4M Sell
291,832
-138,468
-32% -$15.7M 0.01% 1015
2016
Q1
$46.6M Sell
430,300
-21,300
-5% -$2.21M 0.01% 849
2015
Q4
$46.4M Buy
451,600
+8,700
+2% +$875K 0.01% 840
2015
Q3
$41.3M Buy
442,900
+302,600
+216% +$29.3M 0.01% 871
2015
Q2
$13.7M Sell
140,300
-101,400
-42% -$10.2M ﹤0.01% 1680
2015
Q1
$24.3M Sell
241,700
-120,150
-33% -$12.2M 0.01% 1301
2014
Q4
$37.8M Buy
361,850
+272,950
+307% +$28.8M 0.01% 1082
2014
Q3
$9.48M Sell
88,900
-211,856
-70% -$22M ﹤0.01% 1955
2014
Q2
$31.5M Buy
+300,756
New +$30.4M 0.01% 1087
2014
Q1
Sell
-1,221,878
Closed -$112M 3748
2013
Q4
$112M Buy
1,221,878
+544,878
+80% +$50.2M 0.03% 493
2013
Q3
$58.7M Sell
677,000
-23,600
-3% -$2.12M 0.02% 721
2013
Q2
$60.2M Buy
+700,600
New +$59.5M 0.02% 684

Other funds holding JNJ

JP Morgan Chase's JNJ Position: Q1 2026 in Review

JP Morgan Chase increased its Johnson & Johnson (JNJ) stake by 7.7% in Q1 2026, buying an estimated $1.06B and bringing the position to 63,096,344 shares worth $15.3B. The position accounts for 0.98% of the portfolio, ranked #13.

JP Morgan Chase first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • JP Morgan Chase held 63,096,344 shares of Johnson & Johnson worth $15.3B as of Q1 2026.
  • JP Morgan Chase bought 4,538,106 Johnson & Johnson shares in Q1 2026, an estimated $1.06B.
  • Johnson & Johnson made up 0.98% of JP Morgan Chase's portfolio in Q1 2026, its #13 holding.
  • JP Morgan Chase first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.